<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/ACE08F7D-0E5C-4213-BF46-7C1A9DDD8B2C"><gtr:id>ACE08F7D-0E5C-4213-BF46-7C1A9DDD8B2C</gtr:id><gtr:name>Regional Government of Valencia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2F758D8B-A2A4-48F7-A39A-384CC5969C3C"><gtr:id>2F758D8B-A2A4-48F7-A39A-384CC5969C3C</gtr:id><gtr:name>Tufts Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0719BE0D-CCE5-4FEA-BD59-08BFA7F0E516"><gtr:id>0719BE0D-CCE5-4FEA-BD59-08BFA7F0E516</gtr:id><gtr:name>University Hospital Southampton NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Trust Management Offices Mailpoint 18, Tremona Road</gtr:line1><gtr:city>Southampton</gtr:city><gtr:postCode>SO16 6YD</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Human Genetics</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ACE08F7D-0E5C-4213-BF46-7C1A9DDD8B2C"><gtr:id>ACE08F7D-0E5C-4213-BF46-7C1A9DDD8B2C</gtr:id><gtr:name>Regional Government of Valencia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2F758D8B-A2A4-48F7-A39A-384CC5969C3C"><gtr:id>2F758D8B-A2A4-48F7-A39A-384CC5969C3C</gtr:id><gtr:name>Tufts Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0719BE0D-CCE5-4FEA-BD59-08BFA7F0E516"><gtr:id>0719BE0D-CCE5-4FEA-BD59-08BFA7F0E516</gtr:id><gtr:name>University Hospital Southampton NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Trust Management Offices Mailpoint 18, Tremona Road</gtr:line1><gtr:city>Southampton</gtr:city><gtr:postCode>SO16 6YD</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7EC753F1-E3A8-467C-A704-08B2C674B77C"><gtr:id>7EC753F1-E3A8-467C-A704-08B2C674B77C</gtr:id><gtr:firstName>Miodrag</gtr:firstName><gtr:surname>Stojkovic</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6C390F14-5CCF-40E3-A4DD-66741DE6376B"><gtr:id>6C390F14-5CCF-40E3-A4DD-66741DE6376B</gtr:id><gtr:firstName>Tom</gtr:firstName><gtr:surname>Strachan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F31D4947-708C-4E72-8A87-651B54C39C8B"><gtr:id>F31D4947-708C-4E72-8A87-651B54C39C8B</gtr:id><gtr:firstName>Majlinda</gtr:firstName><gtr:surname>Lako</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6C4735F4-44A5-49A7-A19B-3AFF802A1450"><gtr:id>6C4735F4-44A5-49A7-A19B-3AFF802A1450</gtr:id><gtr:firstName>Alison</gtr:firstName><gtr:surname>Murdoch</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0301182"><gtr:id>37755679-2B3B-42B1-9B66-B2D86C50F787</gtr:id><gtr:title>Towards establishing clinical-grade human embryonic stem cell lines</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0301182</gtr:grantReference><gtr:abstractText>Human embryonic stem cells (hESC) are derived from surplus embryos made available through in vitro fertilization programmes. These cells are very much like the cells of the early embryo and they retain the ability to make all the different specialized types of cells in our organs and tissues e.g. blood cells, brain cells, skin cells etc.&amp;nbsp; By culturing hESC in laboratory conditions we can study how these cells develop into the specialised cells of our organs and tissues. There is also the future prospect of using hESC to generate specialised cells that can be used to treat degenerative diseases that would benefit from stem cell transplantation (e.g. in diabetes, heart disease, Parkinson disease etc) or accidental injuries (e.g. skin burns). We have been able to derive hES-NCL1 embryonic stem cell line in 2004. However, the derivation and culture process for this cell line was done in the presence of foreign (mouse) cells and/or chemicals derived from animals. Although this cell line provides an excellent tool for basic research, it is unsuitable for clinical applications.&amp;nbsp; 

The object of this application is to develop specialised laboratory and culture techniques so that new lines of hESC can be isolated and expanded under conditions whereby they are not exposed to animal cells or to animal products. Such cells would then have the potential to be used in treating patients (stem cell therapy).</gtr:abstractText><gtr:technicalSummary>Human embryonic stem cells are pluripotent cells derived from the inner cell mass of blastocysts. They can be differentiated into numerous cell types and as such they offer new opportunities for cell replacement therapies, drug discovery and understanding of human embryonic development. 

We have been successful in deriving a new fully characterised human embryonic stem cell line (hES-NCL1). We are culturing this cell line on novel human feeder cells which we have recently derived, and extracellular matrix (ECM) protein supplemented with the conditioned medium from these feeders. All the available human ES cell lines have been derived in the presence of animal ingredients, but our novel human feeders offer great advantages for deriving clinical grade human ES cell lines without the risk of pathogen transfer from animal based ingredients. We intend to improve xeno-free and feeder-free culture conditions by using human feeders and new human components of the ECM with the conditioned medium derived from our novel feeders.</gtr:technicalSummary><gtr:fund><gtr:end>2009-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>260028</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Cellular Medicine</gtr:department><gtr:description>collaboration with Dr. Sophie Hambleton's group</gtr:description><gtr:id>19043E39-9ED9-4FB8-8AB5-F78EBBF30E23</gtr:id><gtr:impact>Dr. Hambleton has applied for an MRC senior fellowship</gtr:impact><gtr:outcomeId>H7wxoGQ4kZR-1</gtr:outcomeId><gtr:partnerContribution>provision of primary fibroblasts samples from patients and acquisition of ethical permission</gtr:partnerContribution><gtr:piContribution>our groups have been deriving iPSC lines from patients with hematopoietic deficiencies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Regenerative Medicine</gtr:department><gtr:description>collaboration with MRC Centre for Regenerative Medicine Centre Edinburgh</gtr:description><gtr:id>0C005F56-8CD5-4794-80A5-31DAE21ACE19</gtr:id><gtr:impact>award of a MRC clinical fellowship to Dr. Rolan Megan</gtr:impact><gtr:outcomeId>H4zV1tBeEcu-1</gtr:outcomeId><gtr:partnerContribution>provision of antibodies</gtr:partnerContribution><gtr:piContribution>We are transferring our retinal differentiation skills and protcols to the group led by Prof. Charles Ffrench Constant</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Ophthalmology UCL</gtr:department><gtr:description>collaboration with Prof. Robin Ali</gtr:description><gtr:id>8139188B-4CE9-4916-9691-CB5BED50E5A4</gtr:id><gtr:impact>succesful award from Fight for Sight UK (two year project grant)</gtr:impact><gtr:outcomeId>e4weD9rFS5V-1</gtr:outcomeId><gtr:partnerContribution>provision of skils, murine models and transplantation techniques</gtr:partnerContribution><gtr:piContribution>Our research groups are testing in collaboration the engraftment of hESC/hiPSC derived photoreceptor precursors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Genetic Medicine</gtr:department><gtr:description>collaboration with Prof. Chinnery's group</gtr:description><gtr:id>885C3FC1-C93A-494A-9245-09C199184AF1</gtr:id><gtr:impact>award of a three year project grant by BBSRC</gtr:impact><gtr:outcomeId>sDnSqb9D1ey-1</gtr:outcomeId><gtr:partnerContribution>our groups have been deriving iPSC lines from patients with mitochondrial disorders</gtr:partnerContribution><gtr:piContribution>our groups have been deriving iPSC lines from patients with mitochondrial disorders</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Regional Government of Valencia</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Pr?ncipe Felipe Research Centre (CIPF)</gtr:department><gtr:description>collaboration with CIPF, Valencia, Spain</gtr:description><gtr:id>D15CE762-FD80-4D95-B269-58D3667B0939</gtr:id><gtr:impact>Several publications resulted from this collaboration and the PMID numbers are outlined below:
PMID: 20882529
PMID: 20235273
PMID: 2007308</gtr:impact><gtr:outcomeId>LxE9V8Wsu7U-1</gtr:outcomeId><gtr:partnerContribution>Centro de Investigacion Principe Felipe provided laboratory space, reagents and staff costs to enable myself and some members of my group to carry out a one year sabbatical vocation during which we concentrated on studies of signalling pathways in hESC and methods to increase the efficiency of iPSC derivation. At this time we forged strong links with Prof. Dopazo's group and initiated a number of bioinformatics expression studies which are still ongoing.</gtr:partnerContribution><gtr:piContribution>We have a strong collaboration with Prof. Ximo Dopazo's group for bioinformatics analysis of RNA seq data.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biomedical Science</gtr:department><gtr:description>International Stem Cell Initiative</gtr:description><gtr:id>5E2F9FE1-3CF4-4CCF-9931-DD8B76152E85</gtr:id><gtr:impact>This has resulted in 4 publication as follows: 17572666, 16990582, 15342943 and the manuscript that is under revision by Stem Cells shown in publication section.</gtr:impact><gtr:outcomeId>1EEBD743387-1</gtr:outcomeId><gtr:partnerContribution>This is part of the International Stem Cell Initiative (ISCI) spearheaded by Prof. Peter Andrews at Sheffield University. My group has been part of ISCI 1 and 2 and I have participated in the annual conferences organised at Bar Harbor, USA. The results of these initiatives have helped the characterisation of the nine human embryonic stem cell lines derived by our group (and already reported in Stem Cells 2006; 24: 2669-2776 and Stem Cells 22: 790-797) as well as characterisation of newly derived iPSC lines (reported in Stem cells Armstrong et al. 2009, under revision).</gtr:partnerContribution><gtr:piContribution>We used the first human embryonic stem cell derived by our group, hES-NCL1 to be included in ICSI 1 and 2. Samples of RNA and DNA were used for expression, methylation and epigenetic analyses. In addition, in house characterisation of cell surface markers by flow cytometry and immunocytochemistry was submitted to ISCI 1 for data comparison with other human ESC lines.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Southampton University Hospitals NHS Trust (SUHT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>non degradable substrates for RPE cell culture</gtr:description><gtr:id>AE65CBB7-CC00-4A05-B702-67E2358A3625</gtr:id><gtr:impact>multi-disciplinary</gtr:impact><gtr:outcomeId>iJM2sHWRJSq-2</gtr:outcomeId><gtr:partnerContribution>1. Dr Carl Sheridan and Dr. Andrew Lotery have provided for us FDA approved non degradable substrates that have been tested by his group for retinal pigmented epithelial (RPE) cell culture and transplantation in a rabbit model of retinal degeneration. We have started to test these substrates for combined expansion of pluripotent- stem cell-derived photoreceptors and RPE with the aim of optimising culture conditions and delivering human cells suitable for clinical transplantation.</gtr:partnerContribution><gtr:piContribution>we provide the pluripotent stem cell derived RPE and photoreceptors</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tufts Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>collaboration between Tufts Medical Centre and my group</gtr:description><gtr:id>6822D215-B211-4C69-83D7-4F7435080456</gtr:id><gtr:impact>Notable outputs comprise the following publications: 19305136, 19139263,18806832, 18521083, 1863806</gtr:impact><gtr:outcomeId>9CE12FECBE8-1</gtr:outcomeId><gtr:partnerContribution>We over-expressed human NANOG in human ESC with the aim of identifying new secreted factors that could perhaps be used to further define human ESC media to be applied on GMP laboratories. On the course of this investigation we discovered an important role for NANOG in cell cycle regulation of human ESC. This was a new area of investigation for my group and Prof. Hind&amp;acute;s group expertise at Tufts Medical Centre was essential in establishment of all cell cycle related techniques and the transfer of such expertise in my group.transfer of skills and expertise in the cell cycle field</gtr:partnerContribution><gtr:piContribution>All our gene and protein expression data were made available to our collaborator to enable his comparative cell cycle regulation in neural stem cells to embryonic stem cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Ageing and Chronic Disease</gtr:department><gtr:description>non degradable substrates for RPE cell culture</gtr:description><gtr:id>7A36FF36-6D61-4DD0-9FF6-F401845BBE4D</gtr:id><gtr:impact>multi-disciplinary</gtr:impact><gtr:outcomeId>iJM2sHWRJSq-1</gtr:outcomeId><gtr:partnerContribution>1. Dr Carl Sheridan and Dr. Andrew Lotery have provided for us FDA approved non degradable substrates that have been tested by his group for retinal pigmented epithelial (RPE) cell culture and transplantation in a rabbit model of retinal degeneration. We have started to test these substrates for combined expansion of pluripotent- stem cell-derived photoreceptors and RPE with the aim of optimising culture conditions and delivering human cells suitable for clinical transplantation.</gtr:partnerContribution><gtr:piContribution>we provide the pluripotent stem cell derived RPE and photoreceptors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>collaboration with Dr. Saretzki and Prof. von Zglinicki</gtr:description><gtr:id>A68BC939-D108-47A6-8BE9-8A35020A0E71</gtr:id><gtr:impact>23818183
23722522
23280624
22311747
20073085
18203676
18055443
15790773
15536187
15511642</gtr:impact><gtr:outcomeId>5453a83f6c0c58.67329359-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators provide advice and assistance on telomerase, DNA damage and oxidative stress measurement assays.</gtr:partnerContribution><gtr:piContribution>We are interested in the role of telomerase, DNA damage and oxidative stress in ESC and iPSC as well as their derivatives for disease modelling studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sussex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>collaboration with Prof. Penny Jeggo's group</gtr:description><gtr:id>73273DC0-23A8-433E-8399-6E6762463E05</gtr:id><gtr:impact>Publications: 23818183, 23722522</gtr:impact><gtr:outcomeId>LD5wqThjrQL-1</gtr:outcomeId><gtr:partnerContribution>provision of patient specific samples and data analysis</gtr:partnerContribution><gtr:piContribution>We have derived the iPSC lines from samples sent by Jeggo group and have fully characterised those in close collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tufts Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>collaboration between Tufts Medical Centre and my group</gtr:description><gtr:id>19ADE1EA-EA80-4E09-862B-EC999E5F2601</gtr:id><gtr:impact>Notable outputs comprise the following publications: 19305136, 19139263,18806832, 18521083, 1863806</gtr:impact><gtr:outcomeId>9CE12FECBE8-2</gtr:outcomeId><gtr:partnerContribution>We over-expressed human NANOG in human ESC with the aim of identifying new secreted factors that could perhaps be used to further define human ESC media to be applied on GMP laboratories. On the course of this investigation we discovered an important role for NANOG in cell cycle regulation of human ESC. This was a new area of investigation for my group and Prof. Hind&amp;acute;s group expertise at Tufts Medical Centre was essential in establishment of all cell cycle related techniques and the transfer of such expertise in my group.transfer of skills and expertise in the cell cycle field</gtr:partnerContribution><gtr:piContribution>All our gene and protein expression data were made available to our collaborator to enable his comparative cell cycle regulation in neural stem cells to embryonic stem cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Durham University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>collaboration with Prof. Stefan Pryzborski</gtr:description><gtr:id>27477738-2B33-40E4-91B0-0CFDE0935F8C</gtr:id><gtr:impact>18 in total here are some selected recent one:

 23818183 
 23722522
22311747</gtr:impact><gtr:outcomeId>5453a9199d4fe6.03688605-1</gtr:outcomeId><gtr:partnerContribution>Teratoma analysis and ICC is performed by Przyborski's group.</gtr:partnerContribution><gtr:piContribution>We rely on Prof. Pryzboski's team to do the teratoma analysis for our group. We provide assistance and advice with respect to iPSC culture.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>New tools for treating human inherited diseases</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>871D16A6-909A-4D11-A91D-49695677575F</gtr:id><gtr:impact>Invited speaker: LivES symposium: Embryonic Stem Cells: Paris, 12-13th March 2012

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-4613264617.1499640c26f36e</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EC9DA434-1126-4B24-8362-3336241ED011</gtr:id><gtr:impact>Presented data about human embryonic stem cells and their potential use for biological studies, drug discovery and regenerative medicine.

education of public about stem cell research in UK and worldwide</gtr:impact><gtr:outcomeId>C60674FA780</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Foreign Office travel visit to Israel</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BF5626D4-B3E7-48AF-936B-F405EF547660</gtr:id><gtr:impact>To explain how legislative changes in UK helped the stem cell research to policymakers in Israel

televised debate in Jerusalem followed the talk</gtr:impact><gtr:outcomeId>9F11149AAD8</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scientic visit to Suzhou Nanotechnology Institute China</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C62C6E53-4891-4DBF-A865-70E26FA55C37</gtr:id><gtr:impact>100 research fellow and group leaders attended the talk

collaboration has been established between Dr Dai's group and Lako's group</gtr:impact><gtr:outcomeId>qWkXKrtJ3zY</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at the annual research day organised by Macular Disease society UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A5EC760C-8C19-45F1-8684-9CB16A7D53B8</gtr:id><gtr:impact>Around 80 patients and their families attended this event. Prof. Lako and Dr. Collin delivered two talks on the impact of stem cell developments and technologies on disease modelling and understanding.

We have been asked to participate in the next's year annual event.</gtr:impact><gtr:outcomeId>54590039c01262.85652755</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK-Korea symposium on Guidelines, Ethics and Regulation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DE707081-9AF5-4D07-9273-E620F63399B6</gtr:id><gtr:impact>Talk about UK regulation on human ESC derivation and nuclear transfer

large audience (500 people)</gtr:impact><gtr:outcomeId>690CA7C5C45</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>talk at the science and technology select commitee, House of Commons</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>50EE9A40-A3E4-4400-860A-07E7860903B5</gtr:id><gtr:impact>to lobby in favour of the changes proposed for the new HFEA BILL (now the act)

press conference followed the talk to select commitee</gtr:impact><gtr:outcomeId>E1D9DA368DD</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Using stem cells to understand our development and human disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4B3C55FE-053C-46C3-9BB9-68D17B6304F0</gtr:id><gtr:impact>Talk

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-975310598.47707920c249f06</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BIO 2008 conference presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>688712A6-8EFC-449D-8EBF-744C4117E2E2</gtr:id><gtr:impact>30 minutes talk to a large audience (25,000 participants)

Radio conference followed the talk</gtr:impact><gtr:outcomeId>F3B7FE046BB</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at the annual research day organised by RP Fighting Blindness UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8B9DBD28-E961-48C8-BDDB-333206FB7BC1</gtr:id><gtr:impact>more than 200 RP patients and their families attended the events as well as health professionals and researchers working in this area

we were asked to participate in the 2014 patient day event organised by RPFB</gtr:impact><gtr:outcomeId>5458fd7f7b81a2.38129644</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>inaugural meeting of Stem Cell Therapy Interest Group, Glasgow</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D907F5E0-D34B-488E-9EB6-50D29121B695</gtr:id><gtr:impact>Lako: keynote speaker

This was an excellent event bringing together stem cell biologists from Glasgow and surrounding regions and great opportunity for networking.</gtr:impact><gtr:outcomeId>JGakD6JVdvH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2200000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Stem cells for biological assays of novel drugs and predictive toxicology</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>STEMBANCC</gtr:fundingRef><gtr:id>0EE6EE29-AC05-4939-B3DB-F05DFE713B7F</gtr:id><gtr:outcomeId>DP1WwwjK6MB</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>166000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fight for Sight UK project grant</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Fight for Sight</gtr:fundingOrg><gtr:id>7FEF875E-4395-4B45-8571-FF6930007A24</gtr:id><gtr:outcomeId>LdBZk1NM1Wn0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>166000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Investigating haematopoietic development in Ligase IV and XLF patients using induced pluripotent stem cells</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>3EA245B9-C203-4C50-A8E6-4694D8A24820</gtr:id><gtr:outcomeId>04B28CBA4450</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC CONSOLIDATOR FELLOWSHIP</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>614620</gtr:fundingRef><gtr:id>60B41202-EB50-4BB0-8F6D-E8806496FCD7</gtr:id><gtr:outcomeId>HQh9L3YwqNN</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Newcastle Healthcare Charity</gtr:department><gtr:description>Newcastle Health Charity project grant</gtr:description><gtr:end>2007-12-02</gtr:end><gtr:fundingOrg>Newcastle upon Tyne Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>0F324404-9C90-4DBA-9A77-3D127EC5780C</gtr:id><gtr:outcomeId>86214396C580</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Single Cell Genomics Unit</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M008886/1</gtr:fundingRef><gtr:id>CFAA7E65-41BC-4FD3-B5CB-DE3BDE15BCF7</gtr:id><gtr:outcomeId>54522c181e7a44.29576927</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Integrated Mres/PhD studentship</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>828B59E9-7EFA-40F0-8AD4-F9650DE02568</gtr:id><gtr:outcomeId>KEYxmrdZwCC</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sir James Knott Trust project grant</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>Sir James Knott Trust</gtr:fundingOrg><gtr:id>DAC5FBE5-ED4C-4B6C-B258-B545654EBBFE</gtr:id><gtr:outcomeId>65EE78E789B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750000</gtr:amountPounds><gtr:country>Spain, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sabbatical fellowship/Conselleria de Sanidad (Generalitat Valenciana), and the Instituto de Salud Carlos III (Ministry of Science and</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Spanish Ministry of Science and Innovation</gtr:fundingOrg><gtr:id>B5087818-737F-44C7-91AE-66014CD8E847</gtr:id><gtr:outcomeId>jdzvBYXpNoR0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>RP Fighting Blindness project grant</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>RP Fighting Blindness</gtr:fundingOrg><gtr:fundingRef>GR584</gtr:fundingRef><gtr:id>44C6356F-8874-4BC2-A351-3A2B52BF7198</gtr:id><gtr:outcomeId>UGcRLctPTXd</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>232500</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>European Bank of induced pluripotent stem cells (EbiSC)</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>EbiSC</gtr:fundingRef><gtr:id>36C817CD-FE23-4BE4-9DFC-9FC39A627C1C</gtr:id><gtr:outcomeId>54522d6a4d4460.95581086</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>41400</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NOVARTIS PROJECT GRANT</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Novartis</gtr:fundingOrg><gtr:id>5744627C-9CCB-4A14-8562-34DA48E51FEE</gtr:id><gtr:outcomeId>euB7ABYJRkK</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC strategic tools and objectives scheme</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/I02333X/1</gtr:fundingRef><gtr:id>3D901C5A-F556-48C3-B888-0FA6C44BC541</gtr:id><gtr:outcomeId>taWPoyxqBJ90</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF PROJECT GRANT</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>67A94A22-3ACF-4D02-B715-CD51E200ACAF</gtr:id><gtr:outcomeId>CjvgHY2nEJ7</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>62500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/BBSRC Human iPS cell research project grant</gtr:description><gtr:end>2009-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>FE730CAF-7350-4764-8A89-D3B2FFC287EC</gtr:id><gtr:outcomeId>9A952A00AD30</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>141849</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Equipment Grant</gtr:description><gtr:end>2009-05-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>49F4DDD1-617C-4B03-9B52-85A59ADBE4A4</gtr:id><gtr:outcomeId>5016638348E0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fanconi Anaemia Fund project grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Fanconi Anemia Research Fund (FARF)</gtr:fundingOrg><gtr:id>EEBD27FC-6CC9-4862-87F4-2FA25B17D4F4</gtr:id><gtr:outcomeId>A231179F6CC0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Chronic Granulomatous Disorder (CGD) Research Trust</gtr:department><gtr:description>Chronic Granulomatous Disease project grant</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>The Chronic Granulomatous Disorder Society</gtr:fundingOrg><gtr:id>3A690D25-8A3F-449A-97D0-BFA6BBFFBCAE</gtr:id><gtr:outcomeId>LdqVqYSxBKg0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>78000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Generation of disease models for Fanconi Anaemia using pluripotent stem cells</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>FF0E18D4-ADEE-4EFD-9ED1-2C29B104B4B7</gtr:id><gtr:outcomeId>YdeNmdFC5kd0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>460000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC project grant</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>DFCF7098-1B2E-4D35-8FBD-E08EDE081711</gtr:id><gtr:outcomeId>cs9AqD5SPBX0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Newcastle Biomedical Research Centre</gtr:department><gtr:description>BRC project grant</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>D0F5F93A-7B55-435E-A6F1-56A7B3E21317</gtr:id><gtr:outcomeId>77FEDE0F0C50</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>625000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/BBSRC Human iPS cell research project grant</gtr:description><gtr:end>2009-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6D46AECB-63EE-4435-86BE-5D7ADA10850D</gtr:id><gtr:outcomeId>D4E91964E390</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>146000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Investigation of the haematopoietic differentiation of human ES cells</gtr:description><gtr:end>2008-07-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>F3EA1CCF-41BC-4E65-A258-B6FDE55E0DC9</gtr:id><gtr:outcomeId>FD9A8C13F0D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2005-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>251513</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Equipment Grant (A state of the art multiparametric flow cytometry analysis system for multidisciplinary stem cell research)</gtr:description><gtr:end>2008-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/E012841/1</gtr:fundingRef><gtr:id>C59C3BB5-C646-4843-9E81-46A351128D67</gtr:id><gtr:outcomeId>D7802EE277F0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Newcastle Healthcare Charity</gtr:department><gtr:description>Newcastle Health Charity project grant</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Newcastle upon Tyne Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>ADC08EBB-7AE8-4FCA-A1AD-C6B2B75551FE</gtr:id><gtr:outcomeId>MPVys4h81Gf0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The patent describes the methods used for the derivation of human ESC lines from arrested and normal embryos as well as derivation of autologous feeder cells.</gtr:description><gtr:grantRef>G0301182</gtr:grantRef><gtr:id>8CA28C09-4517-47DE-9A54-81F7BB26D7C9</gtr:id><gtr:impact>Autologous feeder cells are routinely being used for derivation of human ESC and more recently promoted to be the best feeder layer for efficient derivation of hiPSC. Derivation of hESC from arrested embryos has also been validates as way forward in many catholic countries like Switzerland since it does not involve usage of good quality embryos that are a priority for reproductive purposes.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>AB26D8843FB</gtr:outcomeId><gtr:patentId>WO2005080551</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>WO 2005/080551A2 (Stem Cells)</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Evidence session for the select committee for the Science and Technology at the House of Commons. This served to gather evidence for proposed changes to the HFEA bill.</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>40B93656-15EE-43AF-8995-140D1369BF6E</gtr:id><gtr:impact>The impact of this and other evidence sessions was to formulate the changes to the HFEA bill that resulted in this becoming law in November 2008; The most notable achievement was that our group was awarded a licence from the HFEA to permit interspecies somatic cell nuclear transfer (human into animal) following the evidence and our group&amp;acute;s work with human embryonic stem cells.</gtr:impact><gtr:outcomeId>5B5C5A3971A</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Nine new human ESC lines were derived during the G0301182 MRC funded study and these have been deposited at the UK Stem Cell Bank. More than 50 hiPSC lines have also been derived with the supplementary funding received in 2009 as extension to this project.</gtr:description><gtr:id>48935D9A-A4B0-4835-9719-A794990632C2</gtr:id><gtr:impact>The nine new cell lines and their characteristics have been registered in the EU hESC registry which will promote interactions between european stem cells scientists. In addition, two of published iPSC lines have been sent to our collaborators in Madison, USA and Oxford UK for further studies.</gtr:impact><gtr:outcomeId>C918AB1623B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>hES-NCL1 - 9 and NCL hiPSC 1 -50</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>human iPSC lines from patients with Fanconi Anaemia (type C), Ligase IV and XLF deficient patients, CGD patients, Muscular Dystrophy and HLHS patients</gtr:description><gtr:id>74E10AD1-B917-422B-9857-ECF05A53EF22</gtr:id><gtr:impact>several publications have risen from this work as follows; 22311747
23818183 
23722522
23280624 
23582880</gtr:impact><gtr:outcomeId>FudrZuiErH9</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>human iPSC lines from diseased individuals</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Affymetrix transcriptional data has been generated for the hES-NCL1, H9 and H1 human ESC lines and embryoid bodies (day6, day10, day 14, day 21) derived from them.</gtr:description><gtr:id>0C0F4154-D1B7-443E-BD5F-F14EC90FA169</gtr:id><gtr:impact>We are using the &amp;quot;know how&amp;quot; from this exercise to analyse transcriptional data generated from hESC derived haematopoietic stem cells. The set of transcriptional data has been sent to our collaborators in Sweden, Australia and Spain to enable large scale comparisons with other human ESC lines.</gtr:impact><gtr:outcomeId>BAB7E62DC99</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>transcriptional data</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B3CF59DF-F48D-4C90-84AB-C675887EA22C</gtr:id><gtr:title>An Induced Pluripotent Stem Cell Patient Specific Model of Complement Factor H (Y402H) Polymorphism Displays Characteristic Features of Age-Related Macular Degeneration and Indicates a Beneficial Role for UV Light Exposure.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76708d8dfc40b9538f53c0c4ef1008cc"><gtr:id>76708d8dfc40b9538f53c0c4ef1008cc</gtr:id><gtr:otherNames>Hallam D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>5a9dbaec3fa2d8.14010017</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE61E228-6785-447B-9F37-BB82E6387DC4</gtr:id><gtr:title>An important role for adenine, cholera toxin, hydrocortisone and triiodothyronine in the proliferation, self-renewal and differentiation of limbal stem cells in&amp;nbsp;vitro.</gtr:title><gtr:parentPublicationTitle>Experimental eye research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a0029150620f65feff65f8b10d27745"><gtr:id>6a0029150620f65feff65f8b10d27745</gtr:id><gtr:otherNames>Yu M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0014-4835</gtr:issn><gtr:outcomeId>58ab4f4257a0b0.46271663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>573FC802-BDE7-4E27-8272-D1FCAA261731</gtr:id><gtr:title>A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31c74aba4bcf852a6649ec5235a6b1ef"><gtr:id>31c74aba4bcf852a6649ec5235a6b1ef</gtr:id><gtr:otherNames>Tilgner K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_14731_21_23722522</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80DDB28A-C0DA-4AD4-B7AD-27C61DA32468</gtr:id><gtr:title>An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8819ec14b0df8cc20dec05313086e46a"><gtr:id>8819ec14b0df8cc20dec05313086e46a</gtr:id><gtr:otherNames>Stojkovic P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>3CB0750FA98</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A89A0B60-1E5E-4A9C-AA2A-25CFBE61148C</gtr:id><gtr:title>Concise Review: Getting to the Core of Inherited Bone Marrow Failures.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ec93291033fb46554d744cbc2525eed"><gtr:id>1ec93291033fb46554d744cbc2525eed</gtr:id><gtr:otherNames>Adam S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>58ab4ea8ddf6a1.85740712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB32AF0A-DC64-4E69-A3B8-425DD8FAB29D</gtr:id><gtr:title>A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/851a472230d2cd69a9cab22daa89e275"><gtr:id>851a472230d2cd69a9cab22daa89e275</gtr:id><gtr:otherNames>Yang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_14731_11_18203676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D616F738-877E-45DF-B27A-D10916252202</gtr:id><gtr:title>Ethical and Safety Issues of Stem Cell-Based Therapy.</gtr:title><gtr:parentPublicationTitle>International journal of medical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87c2443c8230d734d41bf2796d01760c"><gtr:id>87c2443c8230d734d41bf2796d01760c</gtr:id><gtr:otherNames>Volarevic V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1449-1907</gtr:issn><gtr:outcomeId>5a9dba40e4e208.64575039</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F1A5391-2B22-4652-90B3-B96D3B830F5F</gtr:id><gtr:title>Brief report: a human induced pluripotent stem cell model of cernunnos deficiency reveals an important role for XLF in the survival of the primitive hematopoietic progenitors.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31c74aba4bcf852a6649ec5235a6b1ef"><gtr:id>31c74aba4bcf852a6649ec5235a6b1ef</gtr:id><gtr:otherNames>Tilgner K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_14731_21_23818183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>919C02E0-224B-4D48-92FD-F57F0E7C5FBB</gtr:id><gtr:title>Epigenetic modification is central to genome reprogramming in somatic cell nuclear transfer.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35327529ca4f1df9cff05f5b7d814159"><gtr:id>35327529ca4f1df9cff05f5b7d814159</gtr:id><gtr:otherNames>Armstrong L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>000D017CA42</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B944FFD-91C0-403F-9303-DB9A2CBAEBCD</gtr:id><gtr:title>Human-serum matrix supports undifferentiated growth of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8819ec14b0df8cc20dec05313086e46a"><gtr:id>8819ec14b0df8cc20dec05313086e46a</gtr:id><gtr:otherNames>Stojkovic P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>A277C51A026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56A9E5A6-BBA8-482E-AE85-21BD7606943D</gtr:id><gtr:title>Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba0b6035e4458fc14d9c61658be76e45"><gtr:id>ba0b6035e4458fc14d9c61658be76e45</gtr:id><gtr:otherNames>De Sousa PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>5a9dbbbf1ed180.92255928</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A24C15EC-2D93-4BB3-AD10-826F3CABE822</gtr:id><gtr:title>A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef36901ff24201f5a9ef60f60233e6a5"><gtr:id>ef36901ff24201f5a9ef60f60233e6a5</gtr:id><gtr:otherNames>Majlinda Lako (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:isbn>1540-8140</gtr:isbn><gtr:outcomeId>m_9262011369139862b0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FFC3C10-4E36-495A-94C9-65BA6D7E968B</gtr:id><gtr:title>Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7d6414b5561959e026a21adb7b56753"><gtr:id>f7d6414b5561959e026a21adb7b56753</gtr:id><gtr:otherNames>Jiang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_14731_21_22311747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4793D659-645E-4791-AC5B-565DCC49AB7E</gtr:id><gtr:title>G1 to S transition and pluripotency: two sides of the same coin?</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef36901ff24201f5a9ef60f60233e6a5"><gtr:id>ef36901ff24201f5a9ef60f60233e6a5</gtr:id><gtr:otherNames>Majlinda Lako (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:isbn>1551-4005</gtr:isbn><gtr:outcomeId>m_55379160591398539c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13E26215-015F-4DB2-9BC1-F6A83260A0C1</gtr:id><gtr:title>G1 to S phase cell cycle transition in somatic and embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Journal of anatomy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4725828763ea18f9bb08c64817c6472f"><gtr:id>4725828763ea18f9bb08c64817c6472f</gtr:id><gtr:otherNames>Neganova I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-8782</gtr:issn><gtr:outcomeId>E05976C14D7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39F95A94-9801-4589-A309-E4D4A450A356</gtr:id><gtr:title>Pluripotent Stem Cell-Derived Hematopoietic Progenitors Are Unable to Downregulate Key Epithelial-Mesenchymal Transition-Associated miRNAs.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1500f94049a2b61dd012a0d0e33a756"><gtr:id>a1500f94049a2b61dd012a0d0e33a756</gtr:id><gtr:otherNames>Meader E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>5a9dba79cb17d6.80989625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EEB7B94-0784-4B4F-931D-71B7B1DD7090</gtr:id><gtr:title>G1 to S transition and pluripotency: two sides of the same coin?</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb15855be4efb413999bcd624a98656e"><gtr:id>cb15855be4efb413999bcd624a98656e</gtr:id><gtr:otherNames>Lako M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>3F689A0F207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28F1B3E8-1CFE-4ECB-96D7-DF876B335299</gtr:id><gtr:title>Concise review: the epigenetic contribution to stem cell ageing: can we rejuvenate our older cells?</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35327529ca4f1df9cff05f5b7d814159"><gtr:id>35327529ca4f1df9cff05f5b7d814159</gtr:id><gtr:otherNames>Armstrong L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>545245068c15e0.18271091</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22D3351B-2DA8-4C49-9616-CFD1D9380768</gtr:id><gtr:title>Putative role of hyaluronan and its related genes, HAS2 and RHAMM, in human early preimplantation embryogenesis and embryonic stem cell characterization.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/296450f418fdb5b05a0c398e2109e783"><gtr:id>296450f418fdb5b05a0c398e2109e783</gtr:id><gtr:otherNames>Choudhary M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>250B4EB8DCB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAD937EE-86B2-4FD9-A3A6-D9DB21FBB44C</gtr:id><gtr:title>Derivation, growth and applications of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d61a61b7d2ee0407b73f296130f13efa"><gtr:id>d61a61b7d2ee0407b73f296130f13efa</gtr:id><gtr:otherNames>Stojkovic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>B9A8369149C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFD01CA1-E20D-4AB0-96D9-9EB753577CD7</gtr:id><gtr:title>Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef36901ff24201f5a9ef60f60233e6a5"><gtr:id>ef36901ff24201f5a9ef60f60233e6a5</gtr:id><gtr:otherNames>Majlinda Lako (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:isbn>1066-5099</gtr:isbn><gtr:outcomeId>m_1311617727139859a0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80606DAE-8D8F-4A88-8D37-947E6B47EB8F</gtr:id><gtr:title>Use of induced pluripotent stem-cell technology to understand photoreceptor cytoskeletal dynamics in retinitis pigmentosa.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9710d3f1bbceff3076101bfa10b46d2"><gtr:id>d9710d3f1bbceff3076101bfa10b46d2</gtr:id><gtr:otherNames>Megaw R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>56c239faea6408.44392459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A94F84B-15CF-49F3-A6A2-C9569F722D74</gtr:id><gtr:title>Non-invasive imaging of stem cells by scanning ion conductance microscopy: future perspective.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part C, Methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4685265a0f29d6350e4c6396a8e5f1ee"><gtr:id>4685265a0f29d6350e4c6396a8e5f1ee</gtr:id><gtr:otherNames>Gorelik J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1937-3384</gtr:issn><gtr:outcomeId>pm_14731_11_19055357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEBC7711-2D38-4C2D-B487-9C1664816ACD</gtr:id><gtr:title>An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4725828763ea18f9bb08c64817c6472f"><gtr:id>4725828763ea18f9bb08c64817c6472f</gtr:id><gtr:otherNames>Neganova I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>cRNM9hc9ePk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A729B6E4-2110-478D-A154-77BA34F64312</gtr:id><gtr:title>A Novel Role for miR-1305 in Regulation of Pluripotency-Differentiation Balance, Cell Cycle, and Apoptosis in Human Pluripotent Stem Cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d349f0ce1af7c8c10ad44a2b44fed65d"><gtr:id>d349f0ce1af7c8c10ad44a2b44fed65d</gtr:id><gtr:otherNames>Jin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>58ab4de5220829.50766235</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>584CFBA2-84C1-4B3A-9AB2-07F1772E6345</gtr:id><gtr:title>Human embryonic stem cells: biology and clinical implications.</gtr:title><gtr:parentPublicationTitle>Expert reviews in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cb39274beceae2c2a442a033a1ed0c2"><gtr:id>5cb39274beceae2c2a442a033a1ed0c2</gtr:id><gtr:otherNames>Hyslop LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1462-3994</gtr:issn><gtr:outcomeId>272E99267BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09A5B877-8B3F-4C1F-8BEA-6BDE8B5E434B</gtr:id><gtr:title>A critical role for p38MAPK signalling pathway during reprogramming of human fibroblasts to iPSCs.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4725828763ea18f9bb08c64817c6472f"><gtr:id>4725828763ea18f9bb08c64817c6472f</gtr:id><gtr:otherNames>Neganova I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58ab4e7f221459.85793713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B588F9C-A083-4059-9272-21704136E7D7</gtr:id><gtr:title>Towards optimisation of induced pluripotent cell culture: Extracellular acidification results in growth arrest of iPSC prior to nutrient exhaustion.</gtr:title><gtr:parentPublicationTitle>Toxicology in vitro : an international journal published in association with BIBRA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6337ed5046f473edbf853595fad98ca"><gtr:id>f6337ed5046f473edbf853595fad98ca</gtr:id><gtr:otherNames>Wilmes A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0887-2333</gtr:issn><gtr:outcomeId>5a9dbb0e5fa6d7.31631625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0819F7BE-1F29-4544-AF9B-EA4E40F59E54</gtr:id><gtr:title>Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>701CE40EAF9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D53DBE1A-9E11-414F-9459-955C0078E4BD</gtr:id><gtr:title>Efficient stage-specific differentiation of human pluripotent stem cells toward retinal photoreceptor cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1f9ae12417e7085ab2d1c329a907993"><gtr:id>b1f9ae12417e7085ab2d1c329a907993</gtr:id><gtr:otherNames>Mellough CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>doi_53cfcafca87e3ae5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8DC9F58-AB7D-4CA1-A58F-444E398BC37C</gtr:id><gtr:title>Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4725828763ea18f9bb08c64817c6472f"><gtr:id>4725828763ea18f9bb08c64817c6472f</gtr:id><gtr:otherNames>Neganova I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>60131587AC9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFFDB65B-1A90-436A-9208-1216E95D5412</gtr:id><gtr:title>Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_14731_21_22119741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3467A2C9-B840-4B56-A7C4-77971D354E17</gtr:id><gtr:title>Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/851a472230d2cd69a9cab22daa89e275"><gtr:id>851a472230d2cd69a9cab22daa89e275</gtr:id><gtr:otherNames>Yang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>56c23a86c54967.67369215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>319618FC-A96D-4230-BA81-10D45D42CED9</gtr:id><gtr:title>JNK/SAPK Signaling Is Essential for Efficient Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4725828763ea18f9bb08c64817c6472f"><gtr:id>4725828763ea18f9bb08c64817c6472f</gtr:id><gtr:otherNames>Neganova I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>56c238b4290e42.84505092</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1105EBBF-BE87-436C-A7A5-271BB7D34DAB</gtr:id><gtr:title>Differences in the Activity of Endogenous Bone Morphogenetic Protein Signaling Impact on the Ability of Induced Pluripotent Stem Cells to Differentiate to Corneal Epithelial-Like Cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b40cf7945c95634503b976eba04296ee"><gtr:id>b40cf7945c95634503b976eba04296ee</gtr:id><gtr:otherNames>Kamarudin TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>5a9dba5b5bfb64.48227318</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9A58A00-D831-4242-9A94-98B8A83B29ED</gtr:id><gtr:title>3D culture of human pluripotent stem cells in RGD-alginate hydrogel improves retinal tissue development.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/681fd0801fd1de7e49ac0cff1382adbc"><gtr:id>681fd0801fd1de7e49ac0cff1382adbc</gtr:id><gtr:otherNames>Hunt NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>58ab4ee0947b04.60252561</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79204903-3827-4600-843B-1AC737E5CB61</gtr:id><gtr:title>Insights into islet development and biology through characterization of a human iPSC-derived endocrine pancreas model.</gtr:title><gtr:parentPublicationTitle>Islets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec988b3a67ed2845ca470b8b54f847d7"><gtr:id>ec988b3a67ed2845ca470b8b54f847d7</gtr:id><gtr:otherNames>van de Bunt M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1938-2014</gtr:issn><gtr:outcomeId>58ab4e1a9de7b8.92960856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21DF9A10-4666-4AF7-991D-521810E86BBA</gtr:id><gtr:title>Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in vitro culture.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d61a61b7d2ee0407b73f296130f13efa"><gtr:id>d61a61b7d2ee0407b73f296130f13efa</gtr:id><gtr:otherNames>Stojkovic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>6B748737A62</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F89CA87B-96C9-4A2F-AB6C-83F06C662382</gtr:id><gtr:title>An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes.</gtr:title><gtr:parentPublicationTitle>Stem cells translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7d6414b5561959e026a21adb7b56753"><gtr:id>f7d6414b5561959e026a21adb7b56753</gtr:id><gtr:otherNames>Jiang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn><gtr:outcomeId>56c23bb54da993.23452110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDB9329A-3DAB-4990-981F-6CFE1CCF94EE</gtr:id><gtr:title>Engraftment's Holy Grail: is one signal enough?</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb15855be4efb413999bcd624a98656e"><gtr:id>cb15855be4efb413999bcd624a98656e</gtr:id><gtr:otherNames>Lako M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>56c23b2adaa3b5.97960975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6EA37A9-41EB-403F-BA4A-4CF38570DBA3</gtr:id><gtr:title>Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d01a076dfa901adae664f235c784a02"><gtr:id>2d01a076dfa901adae664f235c784a02</gtr:id><gtr:otherNames>Saretzki G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_14731_11_18055443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45B82A35-641D-4790-A433-8244BF30500E</gtr:id><gtr:title>Potential for pharmacological manipulation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ff0b01918e51ffde4611885b3795d05"><gtr:id>8ff0b01918e51ffde4611885b3795d05</gtr:id><gtr:otherNames>Atkinson SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_14731_21_22515554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37A3B38E-CB1F-447C-B184-B2FF290FFD31</gtr:id><gtr:title>Dynamics of single human embryonic stem cells and their pairs: a quantitative analysis.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b506380fb863ce14335cc36b0ff39927"><gtr:id>b506380fb863ce14335cc36b0ff39927</gtr:id><gtr:otherNames>Wadkin LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a9dbb9b309d05.26788424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41EDDEEA-D410-432B-8B33-08D65132A43F</gtr:id><gtr:title>Brief report: human pluripotent stem cell models of fanconi anemia deficiency reveal an important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90beae265cc66a609b94676c64beab85"><gtr:id>90beae265cc66a609b94676c64beab85</gtr:id><gtr:otherNames>Yung SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>545248e576ab78.72882679</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6CAE14C-B175-47D1-9236-77A4113399C3</gtr:id><gtr:title>A putative role for the immunoproteasome in the maintenance of pluripotency in human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ff0b01918e51ffde4611885b3795d05"><gtr:id>8ff0b01918e51ffde4611885b3795d05</gtr:id><gtr:otherNames>Atkinson SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_14731_21_22532526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28C82EEF-1D8D-4E97-A512-EFBFB315A1EA</gtr:id><gtr:title>Gamma-irradiated human amniotic membrane decellularised with sodium dodecyl sulfate is a more efficient substrate for the ex vivo expansion of limbal stem cells.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e049a790073c71bf35bd959a4583915"><gtr:id>1e049a790073c71bf35bd959a4583915</gtr:id><gtr:otherNames>Figueiredo GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>5a9dbb6121db89.54689633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74617A0B-B994-4B9A-AD37-FE8D6B6B43EB</gtr:id><gtr:title>Epigenetic marking prepares the human HOXA cluster for activation during differentiation of pluripotent cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ff0b01918e51ffde4611885b3795d05"><gtr:id>8ff0b01918e51ffde4611885b3795d05</gtr:id><gtr:otherNames>Atkinson SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_14731_11_18292213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22DDE2A4-E2A9-481E-8818-69DA7C9541D6</gtr:id><gtr:title>Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee7356765c5a5563807ed5ec37c33018"><gtr:id>ee7356765c5a5563807ed5ec37c33018</gtr:id><gtr:otherNames>Hyslop L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>C599F8D18BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBA5FE8C-712E-43FE-8755-C0379E64F779</gtr:id><gtr:title>Hepatic differentiation of human iPSCs in different 3D models: A comparative study.</gtr:title><gtr:parentPublicationTitle>International journal of molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1230c03e8b66ba007bf9a11acc9a319"><gtr:id>e1230c03e8b66ba007bf9a11acc9a319</gtr:id><gtr:otherNames>Meier F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1107-3756</gtr:issn><gtr:outcomeId>5a9dba96937617.53250369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5B138D6-9907-446A-AACE-7F00812D587F</gtr:id><gtr:title>Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/611bacfb261e714fa4a764f987ab2565"><gtr:id>611bacfb261e714fa4a764f987ab2565</gtr:id><gtr:otherNames>Ledran MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>doi_53d00b00bcab75af</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D39503CB-4C00-4DE3-8C99-37AF83449645</gtr:id><gtr:title>Stem Cells' position statement on hESC research.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d61a61b7d2ee0407b73f296130f13efa"><gtr:id>d61a61b7d2ee0407b73f296130f13efa</gtr:id><gtr:otherNames>Stojkovic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_14731_21_20809560</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FF923FA-056B-46B4-8CC7-0B4F90C29588</gtr:id><gtr:title>Silencing of the expression of pluripotent driven-reporter genes stably transfected into human pluripotent cells.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/424da25bbe587e89ee3712f0b534778a"><gtr:id>424da25bbe587e89ee3712f0b534778a</gtr:id><gtr:otherNames>Stewart R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>pm_14731_11_18588473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D9608A4-9518-49CF-851D-0CB9880AA33F</gtr:id><gtr:title>Human iPSC disease modelling reveals functional and structural defects in retinal pigment epithelial cells harbouring the m.3243A &amp;gt; G mitochondrial DNA mutation.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3f34322e8a12bb45e58953b383666c4"><gtr:id>b3f34322e8a12bb45e58953b383666c4</gtr:id><gtr:otherNames>Chichagova V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a9dbad200c761.70859551</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E2F88F4-38D9-4913-ABB3-751689A939D4</gtr:id><gtr:title>Editorial: Our top 10 developments in stem cell biology over the last 30 years.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35327529ca4f1df9cff05f5b7d814159"><gtr:id>35327529ca4f1df9cff05f5b7d814159</gtr:id><gtr:otherNames>Armstrong L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_14731_21_22162299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77628A86-13C5-442C-BB4D-1934F85ADBDB</gtr:id><gtr:title>Gelsolin dysfunction causes photoreceptor loss in induced pluripotent cell and animal retinitis pigmentosa models.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9710d3f1bbceff3076101bfa10b46d2"><gtr:id>d9710d3f1bbceff3076101bfa10b46d2</gtr:id><gtr:otherNames>Megaw R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a9dbb485c6765.13872263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C7C000F-F806-4203-8736-FB31F512061D</gtr:id><gtr:title>Preferential amplification of a human mitochondrial DNA deletion in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd9a576f69be63bd6635d10f0ff3185b"><gtr:id>dd9a576f69be63bd6635d10f0ff3185b</gtr:id><gtr:otherNames>Russell OM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a9dba097721f8.34566110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>941AE185-79D2-42BE-8F98-29964FA0C10B</gtr:id><gtr:title>A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0d10ae0b5fee7f7d7a790e1b961f1e4"><gtr:id>f0d10ae0b5fee7f7d7a790e1b961f1e4</gtr:id><gtr:otherNames>Zhang X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>AA855207FCE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FD1ED98-4D12-4602-B8D2-4829A3CFEE45</gtr:id><gtr:title>IGF-1 Signaling Plays an Important Role in the Formation of Three-Dimensional Laminated Neural Retina and Other Ocular Structures From Human Embryonic Stem Cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1f9ae12417e7085ab2d1c329a907993"><gtr:id>b1f9ae12417e7085ab2d1c329a907993</gtr:id><gtr:otherNames>Mellough CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>5675e1997324e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC57272A-2FDC-4661-AA63-FB9D365F971D</gtr:id><gtr:title>Isolation of primordial germ cells from differentiating human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31c74aba4bcf852a6649ec5235a6b1ef"><gtr:id>31c74aba4bcf852a6649ec5235a6b1ef</gtr:id><gtr:otherNames>Tilgner K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>doi_53d0830833275d4b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D68552E-7F37-435A-BB71-9AFA27976178</gtr:id><gtr:title>The mitochondrial protein CHCHD2 primes the differentiation potential of human induced pluripotent stem cells to neuroectodermal lineages.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc457f2ca8a244fd9a11f99914aec1bb"><gtr:id>cc457f2ca8a244fd9a11f99914aec1bb</gtr:id><gtr:otherNames>Zhu L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>58ab4f1948e6f4.32283959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>781EFD3F-D9D5-4E70-81AF-71EA2C5C9FDE</gtr:id><gtr:title>Epigenetic landscaping during hESC differentiation to neural cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea73fc9b6c9490dc20f5e73048faf80c"><gtr:id>ea73fc9b6c9490dc20f5e73048faf80c</gtr:id><gtr:otherNames>Golebiewska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>doi_53cfcafca911aee3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F49FC68-45E5-4747-BD39-5E1AC29034EF</gtr:id><gtr:title>Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/711d7c4345cd767e79003f4e4f4b46d2"><gtr:id>711d7c4345cd767e79003f4e4f4b46d2</gtr:id><gtr:otherNames>Allegrucci C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>6CB0213B0D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BACD030-5FBF-42C7-B9C5-74150E5EC0A6</gtr:id><gtr:title>Neural stem cells, a step closer to clinic?</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d61a61b7d2ee0407b73f296130f13efa"><gtr:id>d61a61b7d2ee0407b73f296130f13efa</gtr:id><gtr:otherNames>Stojkovic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_14731_21_21898696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58B49F5C-45DD-4F83-B4F8-81FFB3855BF3</gtr:id><gtr:title>In search of the best candidate for regeneration of ischemic tissues: are embryonic/fetal stem cells more advantageous than adult counterparts?</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9db95209a58785905dd8b647d43f8163"><gtr:id>9db95209a58785905dd8b647d43f8163</gtr:id><gtr:otherNames>Emanueli C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>D285C74BA05</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4929D9F3-BC7C-434C-A139-3CF065F98B38</gtr:id><gtr:title>Opposing putative roles for canonical and noncanonical NF?B signaling on the survival, proliferation, and differentiation potential of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/851a472230d2cd69a9cab22daa89e275"><gtr:id>851a472230d2cd69a9cab22daa89e275</gtr:id><gtr:otherNames>Yang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>doi_53cfcafca9043c4c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E768531-9E8B-4F99-8B94-ADA50C048FBD</gtr:id><gtr:title>Induced pluripotent stem cells : it looks simple but can looks deceive?</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb15855be4efb413999bcd624a98656e"><gtr:id>cb15855be4efb413999bcd624a98656e</gtr:id><gtr:otherNames>Lako M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>fsh4VSYKJWr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C3427B1-0C54-4D8F-B398-2BD202DC4EA3</gtr:id><gtr:title>iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c7b584f1e2653081eccb42b5825ffe4"><gtr:id>9c7b584f1e2653081eccb42b5825ffe4</gtr:id><gtr:otherNames>Melguizo-Sanchis D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a9dba23bd7ba7.80215407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2522C738-D6D9-4113-A13D-F2C15D694B89</gtr:id><gtr:title>Stem Cell-Based Therapy in Transplantation and Immune-Mediated Diseases.</gtr:title><gtr:parentPublicationTitle>Stem cells international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87c2443c8230d734d41bf2796d01760c"><gtr:id>87c2443c8230d734d41bf2796d01760c</gtr:id><gtr:otherNames>Volarevic V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a9dbab30582d2.24349218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEF7896D-A0F4-4206-BF7B-FB92682DA1A9</gtr:id><gtr:title>The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35327529ca4f1df9cff05f5b7d814159"><gtr:id>35327529ca4f1df9cff05f5b7d814159</gtr:id><gtr:otherNames>Armstrong L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>3F57369BD71</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>637FD3BF-4D69-4202-8B6A-4BA499BD6195</gtr:id><gtr:title>Derivation of human embryonic stem cells from developing and arrested embryos.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0d10ae0b5fee7f7d7a790e1b961f1e4"><gtr:id>f0d10ae0b5fee7f7d7a790e1b961f1e4</gtr:id><gtr:otherNames>Zhang X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>F2D9F733486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE03EEB5-675C-4B09-BFD9-B926E2AD94D4</gtr:id><gtr:title>A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>European urology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dc907cd5e9284df572879baedd5e328"><gtr:id>9dc907cd5e9284df572879baedd5e328</gtr:id><gtr:otherNames>Moad M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0302-2838</gtr:issn><gtr:outcomeId>pm_14731_21_23582880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEA25B7E-3AD2-4F8D-9B7B-CB537411C5D7</gtr:id><gtr:title>Stem cells as new agents for the treatment of infertility: current and future perspectives and challenges.</gtr:title><gtr:parentPublicationTitle>BioMed research international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87c2443c8230d734d41bf2796d01760c"><gtr:id>87c2443c8230d734d41bf2796d01760c</gtr:id><gtr:otherNames>Volarevic V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5452466c402a17.00048189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F786E655-8B73-42CC-B9D2-C558FF8D4E23</gtr:id><gtr:title>Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35327529ca4f1df9cff05f5b7d814159"><gtr:id>35327529ca4f1df9cff05f5b7d814159</gtr:id><gtr:otherNames>Armstrong L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>doi_53cfcafca8de1930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>129EFDFF-4C40-4152-A936-81CEED74E0C7</gtr:id><gtr:title>Tissue engineering using pluripotent stem cells: multidisciplinary approaches to accelerate bench-to-bedside transition.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/681fd0801fd1de7e49ac0cff1382adbc"><gtr:id>681fd0801fd1de7e49ac0cff1382adbc</gtr:id><gtr:otherNames>Hunt NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>58ab4fd398fa98.79924568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77F8B46E-3B5B-4BA6-BB2F-6EA48191D1A1</gtr:id><gtr:title>SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f87b4d9f577d6cb8946b3b407d3a1d7b"><gtr:id>f87b4d9f577d6cb8946b3b407d3a1d7b</gtr:id><gtr:otherNames>Real PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>pm_14731_21_22491213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>272201C5-7F73-432D-BD16-52C23E80A06D</gtr:id><gtr:title>Nonintegrating Gene Therapy Vectors.</gtr:title><gtr:parentPublicationTitle>Hematology/oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42cdc5f57f0f1b5cd460cb2c327e80b9"><gtr:id>42cdc5f57f0f1b5cd460cb2c327e80b9</gtr:id><gtr:otherNames>Athanasopoulos T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0889-8588</gtr:issn><gtr:outcomeId>5a34f47917b576.22627373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FFB7C97-7E10-4DA7-B6AA-C1290BE333FC</gtr:id><gtr:title>Large-scale transcriptional profiling and functional assays reveal important roles for Rho-GTPase signalling and SCL during haematopoietic differentiation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b8eba7c7d404762378d7575ce607376"><gtr:id>8b8eba7c7d404762378d7575ce607376</gtr:id><gtr:otherNames>Yung S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>doi_53d04604688ea370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC00596F-E466-4582-82DA-A69CA615FB42</gtr:id><gtr:title>Primordial Germ Cells: Current Knowledge and Perspectives.</gtr:title><gtr:parentPublicationTitle>Stem cells international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1276aaff0693077b8208be1c9c104ba2"><gtr:id>1276aaff0693077b8208be1c9c104ba2</gtr:id><gtr:otherNames>Nikolic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56c23939627736.61698214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0855A48-6CF9-43EF-809D-EDED6E8A1097</gtr:id><gtr:title>How to build a human.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1f9ae12417e7085ab2d1c329a907993"><gtr:id>b1f9ae12417e7085ab2d1c329a907993</gtr:id><gtr:otherNames>Mellough CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>58ab4f9c8858f8.96780043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63CCEBB5-64CD-4160-A3C5-2D551C01C766</gtr:id><gtr:title>Multiplex High-Throughput Targeted Proteomic Assay To Identify Induced Pluripotent Stem Cells.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8624cba5397e3f926bb9992f0b0cc59"><gtr:id>b8624cba5397e3f926bb9992f0b0cc59</gtr:id><gtr:otherNames>Baud A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>58ab4e5805c4f3.61654173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D60BEA02-8DD8-470A-9C87-559365B2669F</gtr:id><gtr:title>Using Zinc Finger Nuclease Technology to Generate CRX-Reporter Human Embryonic Stem Cells as a Tool to Identify and Study the Emergence of Photoreceptors Precursors During Pluripotent Stem Cell Differentiation.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52f57e90923c8c783ce1b858d944c58e"><gtr:id>52f57e90923c8c783ce1b858d944c58e</gtr:id><gtr:otherNames>Collin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>56c2396805c9b7.94903573</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A5E898C-CCB1-464D-A912-3E5368027CB2</gtr:id><gtr:title>Brief Report: Inhibition of miR-145 Enhances Reprogramming of Human Dermal Fibroblasts to Induced Pluripotent Stem Cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a7d043f9ead19fb2476e7ac52aeab9e"><gtr:id>6a7d043f9ead19fb2476e7ac52aeab9e</gtr:id><gtr:otherNames>Barta T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>56c239bf39d050.27713989</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D55D1EA-257F-4F02-9D0F-67AC9F4A19CC</gtr:id><gtr:title>Expression of GFP under the control of the RNA helicase VASA permits fluorescence-activated cell sorting isolation of human primordial germ cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31c74aba4bcf852a6649ec5235a6b1ef"><gtr:id>31c74aba4bcf852a6649ec5235a6b1ef</gtr:id><gtr:otherNames>Tilgner K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_5435ab85ab8bb84d0</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0301182</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>